Cite
MLA Citation
Sonia Pernas et al.. “Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.” Lancet oncology, vol. 19, no. 6, 2018, pp. 812–824. http://access.bl.uk/ark:/81055/vdc_100065599260.0x00000e